Machine Learning

Despite a massive paper loss, Sharplink amassed a huge ETH treasury and grew staking revenue, testing a new model for public company crypto exposure.

A new AI signature from Caris Life Sciences aims to guide first-line therapy for a deadly cancer, facing hurdles of clinical validation and adoption.

The massive rollout of hellocare.ai's platform aims to enhance patient safety and ease nursing shortages, marking a major leap into the future of healthcare.

As it prepares for a Nasdaq listing, quantum software firm Horizon Quantum brings in veterans from Apple, Grab, and Broadcom to navigate its public future.

With one trial halted and another beginning, the company focuses its cash and hopes on BBI-940, a novel drug targeting a fundamental driver of cancer.

A new non-thermal ablation technology shows long-term success in shrinking thyroid nodules with high patient satisfaction, potentially disrupting surgical norms.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.

IDEAYA Biosciences begins a key trial for its targeted therapy IDE892, aiming to conquer hard-to-treat tumors and pivoting to focus on its proprietary assets.

FinVolution Group is set to release its 2025 financials, with investors watching to see if international growth and AI tech can navigate market headwinds.

Patriot Memory's industrial arm, ACPI, unveils extreme-performance PCIe Gen5 SSDs and DDR5 RAM, targeting the demanding AI, edge, and 5G markets.

Moving to FAST platforms, Mind-Sync TV pioneers 'Functional TV,' a new category of 4K content designed to enhance focus, not just entertain.

With a historic $2B Series C and a $14.6B valuation, Nscale is escalating the global race to build the power grid for the AI revolution.

Nordic Semiconductor's new entry-level Bluetooth LE SoCs promise to slash costs, fueling a new wave of affordable smart sensors, tags, and wearables.

Beijing is pouring trillions into AI, 6G, and biomanufacturing to dominate the next tech era, offering Europe partnership amidst rising competition.

A new trial in China tests a dual-action antibody for esophageal cancer, a top killer. The therapy aims to unleash a two-pronged immune attack on tumors.

An in-depth look at the Nooro foot massager reveals a gap between its marketing claims, FDA clearance, and a pattern of customer service complaints.

Dr. Mark Newman earns the prestigious John von Neumann Prize for his foundational work in network science, the hidden math shaping our connected world.

Newrez has again swept Fannie Mae's top honors. Discover how its focus on AI and customer service sets new industry standards for millions of homeowners.

With new CEO Anthony Rotoli and Accel-KKR's backing, MCM Technology aims to conquer the public safety software market through major platform innovation.